Nephros (NEPH) Cash from Investing Activities (2010 - 2022)
Nephros' (NEPH) quarterly Cash from Investing Activities came in at -$103000.0 in Q2 2022, down 202.94% quarter-over-quarter from -$34000.0 in Q1 2022.
Nephros (NEPH) Cash from Investing Activities (2010 - 2022) Analysis & Trends
Nephros' Cash from Investing Activities history runs 8 years deep, the most recent figure standing at -$103000.0 for Q2 2022.
- On a quarterly basis, Cash from Investing Activities changed N/A year-over-year to -$103000.0 in Q2 2022; TTM through Sep 2024 was -$103000.0, a N/A change from a year earlier, with the FY2024 full-year figure at -$50000.0, up 33.33% from the prior year.
- Cash from Investing Activities eased to -$103000.0 in Q2 2022 per NEPH's latest filing, from -$34000.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at -$13000.0 in Q3 2020 and bottomed at -$137000.0 in Q1 2019.
- The 4-year median for Cash from Investing Activities is -$34000.0 (2022), against an average of -$55142.9.
- Across the five-year window, Cash from Investing Activities gained 7.14% in 2020 and tumbled 376.92% in 2021, its largest moves.
- Year by year, Cash from Investing Activities stood at -$14000.0 in 2019, then rose by 7.14% to -$13000.0 in 2020, then tumbled by 376.92% to -$62000.0 in 2021, then plunged by 66.13% to -$103000.0 in 2022.
- Per Business Quant, the three latest NEPH Cash from Investing Activities figures stand at -$103000.0 (Q2 2022), -$34000.0 (Q1 2022), and -$62000.0 (Q3 2021).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 125.00 Bn | 119.78 Bn | 1.96 Bn | -26.60 Mn |
| 2 | Becton Dickinson | 44.35 Bn | 43.53 Bn | 2.15 Bn | -139.00 Mn |
| 3 | Alcon | 33.11 Bn | 31.45 Bn | 1.53 Bn | -218.00 Mn |
| 4 | Medline | 32.71 Bn | 30.47 Bn | 1.84 Bn | -96.00 Mn |
| 5 | Resmed | 29.03 Bn | 27.37 Bn | 890.98 Mn | -58.03 Mn |
| 6 | West Pharmaceutical Services | 23.69 Bn | 23.25 Bn | 329.20 Mn | -43.20 Mn |
| 7 | Solventum | 13.91 Bn | 13.35 Bn | 1.10 Bn | -77.00 Mn |
| 8 | Cooper Companies | 13.82 Bn | 13.68 Bn | 735.40 Mn | -90.00 Mn |
| 9 | Align Technology | 12.16 Bn | 11.10 Bn | 736.59 Mn | -131.58 Mn |
| 10 | Nephros | 36.49 Mn | 32.47 Mn | 2.99 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -103,000.00 |
| Jun 30, 2022 | -103,000.00 |
| Mar 31, 2022 | -34,000.00 |
| Mar 31, 2022 | -34,000.00 |
| Sep 30, 2021 | -62,000.00 |
| Sep 30, 2021 | -62,000.00 |
| Mar 31, 2021 | -23,000.00 |
| Mar 31, 2021 | -23,000.00 |
| Sep 30, 2020 | -13,000.00 |
| Sep 30, 2020 | -13,000.00 |
| Sep 30, 2019 | -14,000.00 |
| Sep 30, 2019 | -14,000.00 |
| Mar 31, 2019 | -137,000.00 |
| Mar 31, 2019 | -137,000.00 |
| Sep 30, 2016 | -5,000.00 |
| Sep 30, 2016 | -5,000.00 |
| Jun 30, 2016 | -14,000.00 |
| Jun 30, 2016 | -14,000.00 |
| Mar 31, 2016 | -26,000.00 |
| Mar 31, 2016 | -26,000.00 |